Year |
Citation |
Score |
2023 |
Rudqvist NP, Charpentier M, Lhuillier C, Wennerberg E, Spada S, Sheridan C, Zhou XK, Zhang T, Formenti SC, Sims JS, Alonso A, Demaria S. Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors. Nature Communications. 14: 5146. PMID 37620372 DOI: 10.1038/s41467-023-40844-3 |
0.352 |
|
2023 |
Stagg J, Golden E, Wennerberg E, Demaria S. The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Science Immunology. 8: eabq3015. PMID 37418547 DOI: 10.1126/sciimmunol.abq3015 |
0.327 |
|
2022 |
Wennerberg E, Mukherjee S, Sainz RM, Stiles BM. The ART of tumor immune escape. Oncoimmunology. 11: 2076310. PMID 35602287 DOI: 10.1080/2162402X.2022.2076310 |
0.462 |
|
2022 |
Wennerberg E, Mukherjee S, Spada S, Hung C, Agrusa CJ, Chen C, Valeta-Magara A, Rudqvist NP, Van Nest SJ, Kamel MK, Nasar A, Narula N, Mittal V, Markowitz GJ, Zhou XK, et al. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Science Translational Medicine. 14: eabe8195. PMID 35294260 DOI: 10.1126/scitranslmed.abe8195 |
0.452 |
|
2021 |
Yamazaki T, Wennerberg E, Hensler M, Buqué A, Kraynak J, Fucikova J, Zhou XK, Sveinbjørnsson B, Rekdal Ø, Demaria S, Galluzzi L. LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology. 10: 1962592. PMID 34408925 DOI: 10.1080/2162402X.2021.1962592 |
0.371 |
|
2021 |
Wennerberg E, Lundqvist A, Mao Y, Mougiakakos D. Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy. Frontiers in Immunology. 12: 718844. PMID 34276709 DOI: 10.3389/fimmu.2021.718844 |
0.703 |
|
2020 |
Spada S, Rudqvist NP, Wennerberg E. Isolation of DNA from exosomes. Methods in Enzymology. 636: 173-183. PMID 32178818 DOI: 10.1016/Bs.Mie.2020.01.012 |
0.396 |
|
2020 |
Wennerberg E, Rudqvist NP, Spada S. Characterization of conventional dendritic cell populations in preclinical tumor models using flow cytometry. Methods in Enzymology. 635: 139-148. PMID 32122542 DOI: 10.1016/Bs.Mie.2020.01.011 |
0.509 |
|
2020 |
Wennerberg E, Lhuillier C, Rybstein MD, Dannenberg K, Rudqvist NP, Koelwyn GJ, Jones LW, Demaria S. Exercise reduces immune suppression and breast cancer progression in a preclinical model. Oncotarget. 11: 452-461. PMID 32064049 DOI: 10.18632/oncotarget.27464 |
0.323 |
|
2020 |
Wennerberg E, Spada S, Rudqvist NP, Lhuillier C, Gruber S, Chen Q, Zhang F, Zhou XK, Gross SS, Formenti SC, Demaria S. CD73 blockade promotes dendritic cell infiltration of irradiated tumors and tumor rejection. Cancer Immunology Research. PMID 32047024 DOI: 10.1158/2326-6066.Cir-19-0449 |
0.489 |
|
2020 |
Mukherjee S, Wennerberg E, Hung C, Saadallah N, Kariyawasam S, Agrusa C, Valeta A, Altorki N, McGraw T, Demaria S, Stiles B. Abstract 1820: Art1, an extracellular mono-ADP-ribosyltransferase, is upregulated in response to cellular stress and promotes lung cancer growth Cancer Research. 80: 1820-1820. DOI: 10.1158/1538-7445.Am2020-1820 |
0.51 |
|
2020 |
Rudqvist N, Zappasodi R, Wells D, Thorsson V, Cogdill A, Monette A, Najjar Y, Sweis R, Wennerberg E, Bommareddy P, Haymaker C, Khan U, McGee H, Park W, Sater HA, et al. P854 Construction of the immune landscape of durable response to checkpoint blockade therapy by integrating publicly available datasets Journal For Immunotherapy of Cancer. 8. DOI: 10.1136/Lba2019.8 |
0.379 |
|
2020 |
Rudqvist N, Lhuillier C, Charpentier M, Wennerberg E, Spada S, Sheridan C, Zhou XK, Zhang T, Sims J, Alonso A, Demaria S. 465 Radiotherapy and CTLA-4 blockade expand anti-tumor T cells differentiation states and cooperate with CD40 agonist to induce tumor rejection Journal For Immunotherapy of Cancer. 8: A494-A495. DOI: 10.1136/jitc-2020-sitc2020.0465 |
0.371 |
|
2020 |
Mukherjee S, Wennerberg E, Hung C, Saadallah N, Kariyawasam S, Hussein M, Narula N, Adusumilli P, Borczuk A, Altorki N, McGraw T, Stiles B. A05 ART1, a Mono-ADP-Ribosyltransferase, Regulates Tumor-Infiltrating CD8+ T Cells and Is Highly Expressed in EGFR Mutated Lung Cancers Journal of Thoracic Oncology. 15: S13. DOI: 10.1016/J.Jtho.2019.12.034 |
0.406 |
|
2019 |
Wennerberg E, Galluzzi L. Born to Kill: NK Cells Go to War against Cancer. Trends in Cancer. 5: 143-145. PMID 30898260 DOI: 10.1016/J.Trecan.2018.12.005 |
0.466 |
|
2018 |
Formenti SC, Rudqvist NP, Golden E, Cooper B, Wennerberg E, Lhuillier C, Vanpouille-Box C, Friedman K, Ferrari de Andrade L, Wucherpfennig KW, Heguy A, Imai N, Gnjatic S, Emerson RO, Zhou XK, et al. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nature Medicine. PMID 30397353 DOI: 10.1038/S41591-018-0232-2 |
0.424 |
|
2018 |
Wennerberg E, Formenti S, Demaria S. Abstract B05: Adenosine generation limits the ability of radiation therapy to induce antitumor immunity by abrogating recruitment and activation of CD103+ DCs Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-B05 |
0.44 |
|
2017 |
Rudqvist NP, Pilones KA, Lhuillier C, Wennerberg E, Sidhom JW, Emerson RO, Robins HS, Schneck J, Formenti SC, Demaria S. Radiotherapy and CTLA-4 blockade shape the TCR repertoire of tumor-infiltrating T cells. Cancer Immunology Research. PMID 29180535 DOI: 10.1158/2326-6066.Cir-17-0134 |
0.507 |
|
2017 |
Kremer V, Ligtenberg MA, Zendehdel R, Seitz C, Duivenvoorden A, Wennerberg E, Colón E, Scherman-Plogell AH, Lundqvist A. Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma. Journal For Immunotherapy of Cancer. 5: 88. PMID 29110706 DOI: 10.1186/S40425-017-0292-8 |
0.75 |
|
2017 |
Wennerberg E, Vanpouille-Box C, Bornstein S, Yamazaki T, Demaria S, Galluzzi L. Immune recognition of irradiated cancer cells. Immunological Reviews. 280: 220-230. PMID 29027232 DOI: 10.1111/Imr.12568 |
0.489 |
|
2017 |
Kremer V, Ligtenberg MA, Zendehdel R, Seitz C, Duivenvoorden A, Wennerberg E, Colón E, Scherman-Plogell AH, Lundqvist A. Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma. Journal For Immunotherapy of Cancer. 5: 73. PMID 28923105 DOI: 10.1186/S40425-017-0275-9 |
0.81 |
|
2017 |
Wennerberg E, Lhuillier C, Vanpouille-Box C, Pilones KA, García-Martínez E, Rudqvist NP, Formenti SC, Demaria S. Barriers to Radiation-Induced In Situ Tumor Vaccination. Frontiers in Immunology. 8: 229. PMID 28348554 DOI: 10.3389/Fimmu.2017.00229 |
0.491 |
|
2016 |
Mao Y, van Hoef V, Zhang X, Wennerberg E, Lorent J, Witt K, Masvidal Sanz L, Liang S, Murray S, Larsson O, Kiessling R, Lundqvist A. IL-15 activates mTOR and primes stress-activated gene-expression leading to prolonged anti-tumor capacity of NK cells. Blood. PMID 27465917 DOI: 10.1182/Blood-2016-02-698027 |
0.761 |
|
2016 |
Althammer S, Steele K, Rebelatto M, Tan TH, Wiestler T, Schmidt G, Higgs B, Li X, Shi L, Jin X, Antal J, Gupta A, Ranade K, Binning G, Bellmunt J, ... ... Wennerberg E, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0191-4 |
0.342 |
|
2016 |
Wennerberg E, Mediero A, Wilder T, Formenti S, Cronstein B, Demaria S. Abstract 4033: Adenosine regulates radiation therapy-induced antitumor immunity Cancer Research. 76: 4033-4033. DOI: 10.1158/1538-7445.Am2016-4033 |
0.552 |
|
2015 |
Vanpouille-Box C, Pilones KA, Wennerberg E, Formenti SC, Demaria S. In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine. 33: 7415-22. PMID 26148880 DOI: 10.1016/J.Vaccine.2015.05.105 |
0.516 |
|
2015 |
Wennerberg E, Kremer V, Childs R, Lundqvist A. CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo. Cancer Immunology, Immunotherapy : Cii. 64: 225-35. PMID 25344904 DOI: 10.1007/S00262-014-1629-5 |
0.811 |
|
2015 |
Lundqvist A, Mao Y, Zhang X, Wennerberg E, Van Hoef V, Larsson O, Linder S, Kiessling R. Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P232 |
0.709 |
|
2015 |
Wennerberg E, Kawashima N, Demaria S. Abstract A21: Adenosine is a rheostat for radiation therapy-induced immune activation Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A21 |
0.525 |
|
2015 |
Wennerberg E, Kawashima N, Demaria S. Adenosine regulates radiation therapy-induced anti-tumor immunity Journal For Immunotherapy of Cancer. 3. DOI: 10.1016/J.Ijrobp.2016.06.308 |
0.371 |
|
2014 |
Wennerberg E, Pfefferle A, Ekblad L, Yoshimoto Y, Kremer V, Kaminskyy VO, Juhlin CC, Höög A, Bodin I, Svjatoha V, Larsson C, Zedenius J, Wennerberg J, Lundqvist A. Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5733-44. PMID 25212604 DOI: 10.1158/1078-0432.Ccr-14-0291 |
0.773 |
|
2014 |
Tittarelli A, Mendoza-Naranjo A, FarÃas M, Guerrero I, Ihara F, Wennerberg E, Riquelme S, Gleisner A, Kalergis A, Lundqvist A, López MN, Chambers BJ, Salazar-Onfray F. Gap junction intercellular communications regulate NK cell activation and modulate NK cytotoxic capacity. Journal of Immunology (Baltimore, Md. : 1950). 192: 1313-9. PMID 24376266 DOI: 10.4049/Jimmunol.1301297 |
0.742 |
|
2013 |
Sarhan D, Wennerberg E, D'Arcy P, Gurajada D, Linder S, Lundqvist A. A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells. Cancer Immunology, Immunotherapy : Cii. 62: 1359-68. PMID 23689729 DOI: 10.1007/S00262-013-1439-1 |
0.82 |
|
2013 |
Mao Y, Poschke I, Wennerberg E, Pico de Coaña Y, Egyhazi Brage S, Schultz I, Hansson J, Masucci G, Lundqvist A, Kiessling R. Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms. Cancer Research. 73: 3877-87. PMID 23633486 DOI: 10.1158/0008-5472.Can-12-4115 |
0.725 |
|
2013 |
Wennerberg E, Sarhan D, Carlsten M, Kaminskyy VO, D'Arcy P, Zhivotovsky B, Childs R, Lundqvist A. Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling. International Journal of Cancer. 133: 1643-52. PMID 23504627 DOI: 10.1002/Ijc.28163 |
0.828 |
|
2013 |
Sarhan D, D'Arcy P, Wennerberg E, Lidén M, Hu J, Winqvist O, Rolny C, Lundqvist A. Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ. European Journal of Immunology. 43: 249-57. PMID 22996291 DOI: 10.1002/Eji.201242735 |
0.838 |
|
2013 |
Mao Y, Poschke I, Coaña YPd, Wennerberg E, Lundqvist A, Kiessling R. Abstract A63: Melanoma-educated CD14+ monocytes become myeloid-derived suppressor cell-like and are potent inhibitors of autologous T cells through Cox-2 production and STAT-3 signaling. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-A63 |
0.719 |
|
2013 |
Wennerberg E, Kremer V, Lundqvist A. Abstract A15: IFN-gamma-inducible-protein-10 stimulates intratumoral infiltration of adoptively transferred human NK cells in a melanoma xenograft mouse model. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-A15 |
0.813 |
|
2012 |
Kiessling R, Okita R, Mougiakakos D, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kono K. Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells. Oncoimmunology. 1: 1200-1201. PMID 23170279 DOI: 10.4161/Onci.20685 |
0.779 |
|
2012 |
Okita R, Mougiakakos D, Ando T, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kiessling R. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines. Journal of Immunology (Baltimore, Md. : 1950). 188: 2136-45. PMID 22301547 DOI: 10.4049/Jimmunol.1102237 |
0.775 |
|
Show low-probability matches. |